Cells expressing alpha-synuclein and uses therefor

Details for Australian Patent Application No. 2007324138 (hide)

Owner FoldRx Pharmaceuticals, Inc.

Inventors Liang, Feng

Agent Cullen & Co

Pub. Number AU-A-2007324138

PCT Pub. Number WO2008/063779

Priority 60/829,320 13.10.06 US

Filing date 12 October 2007

Wipo publication date 29 May 2008

International Classifications

C12N 5/08 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

Event Publications

14 May 2009 PCT application entered the National Phase

  PCT publication WO2008/063779 Priority application(s): WO2008/063779

15 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007324191-Stabilizer device with wheeled guide arm

2007324135-Antibodies to lymphotoxin-alpha